MedTrace Logo

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

NCT06408350 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2026-02-11

No results posted yet for this study

Summary

Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.

Conditions

Interventions

BEHAVIORAL

Text Me, Alexis!

Determine the Optimal Intervention for Advancing Transgender Women Living with HIV to Full Viral Suppression

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    collaborator OTHER

  • Friends Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Cathy J Reback, PhD · Friends Research Institute, Inc.

  • Sean M Murphy, PhD · Weill Medical College of Cornell University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-11
Primary Completion
2025-03-19
Completion
2025-03-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06408350 on ClinicalTrials.gov